-- Australian Clinical Labs (ASX:ACL) said Pinnacle Investment Management Group and its subsidiaries have increased their stake in the company on April 13 to 6.67% or 12.6 million shares from 5.01% or 9.5 million shares, according to a Thursday Australian bourse filing.
Related Articles
Asia
China Minsheng Banking Issues 30 Billion Yuan Tier 2 Capital Bonds
China Minsheng Banking (SHA:600016, HKG:1988) issued Tier 2 capital bonds amounting to 30 billion yuan, according to a Shanghai bourse filing on Wednesday.The 10-year fixed-rate bonds have a coupon rate of 2.13%, with a conditional issuer call option at the end of the fifth year.Proceeds from the issuance will be used to supplement the lender's Tier 2 capital.The bank's Hong Kong shares slipped 1% during the morning trade.
$HKG:1988$SHA:600016
International
Huafon Chemical's Attributable Profit Jumps 33% in Q1
Huafon Chemical's (SHE:002064) attributable profit rose 33% to 668.6 million yuan in the first quarter from 504.3 million yuan in the year-ago period, according to a Tuesday filing with the Shenzhen bourse.Earnings per share at the polyurethane product materials company increased 30% to 0.13 yuan from 0.10 yuan in the prior-year period.Operating income grew 7.2% year over year to 6.77 billion yuan from 6.31 billion yuan.Shares increased 2% during the midday break on Wednesday.
$SHE:002064
Asia
Kaishan 2025 Profit Up 14%, Revenue Rises 12%
Kaishan Group (SHE:300257) posted 2025 attributable net profit of 364.2 million yuan, up 14% from 320.4 million yuan the previous year.Earnings per share rose to 0.37 yuan from 0.32 yuan, according to a Wednesday filing with the Shenzhen bourse.The compressor maker's operating revenue rose 12% year over year to 4.72 billion yuan from 4.23 billion yuan.Shares of the company were down 1% in recent trade.
$SHE:300257